Skip to main content

Mark Shlomchik was elected as an American Association of Immunologists Distinguished Fellow

Mark Shlomchik, UPMC Endowed and distinguished professor in the University of Pittsburgh School of Medicine Department of Immunology, was elected as a 2024 Distinguished Fellow of the American Association of Immunologists (AAI). It is among the highest honors bestowed by the AAI.

Fellowship recognizes active, long-term members who have demonstrated excellence in research accomplishment in the field of immunology, exceptional leadership to the immunology community in academia at a national or international level, and notable distinction as an educator.

Shlomchik, who is also co-founder and was Chief Scientific Officer at Bluesphere Bio, a translational sciences company developing therapies that harness the immune response of patients to cure cancer, was chair of Pitt’s Department of Immunology from 2013-2022. He has made several fundamental contributions to understanding autoimmune diseases and immune responses, most recently in a Nature Immunology study that explains the developmental origins of memory B cells, which underly how vaccines and post-infection immunity are protective.